Hübel, Christopher https://orcid.org/0000-0002-1267-8287
Gaspar, Héléna A. https://orcid.org/0000-0002-5540-2707
Coleman, Jonathan R. I. https://orcid.org/0000-0002-6759-0944
Hanscombe, Ken B.
Purves, Kirstin https://orcid.org/0000-0002-8110-5554
Prokopenko, Inga https://orcid.org/0000-0003-1624-7457
Graff, Mariaelisa
Ngwa, Julius S.
Workalemahu, Tsegaselassie
,
,
,
,
,
,
,
,
,
,
,
,
,
O’Reilly, Paul F. https://orcid.org/0000-0001-7515-0845
Bulik, Cynthia M. https://orcid.org/0000-0001-7772-3264
Breen, Gerome https://orcid.org/0000-0003-2053-1792
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (U01 MH109514)
South London and Maudsley NHS Foundation Trust
Article History
Received: 5 April 2019
Accepted: 8 November 2019
First Online: 18 December 2019
Competing interests
: Dr. Breen has received grant funding from and served as a consultant to Eli Lilly, has received honoraria from Illumina and has served on advisory boards for Otsuka. Dr. Bulik is a grant recipient from and has served on advisory boards for Shire. She receives royalties from Pearson. All interests are unrelated to this work. Dr. Coleman, Dr. Gaspar, Ms. Purves, Dr. Hübel, Dr. Hanscombe, Dr. Prokopenko, Dr. Graff, Dr. Ngwa, Dr. Workalemahu and Dr. O'Reilly declare no competing interests.